David Boucher

405 total citations
7 papers, 334 citations indexed

About

David Boucher is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, David Boucher has authored 7 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in David Boucher's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Cancer Genomics and Diagnostics (4 papers). David Boucher is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Cancer Genomics and Diagnostics (4 papers). David Boucher collaborates with scholars based in United States. David Boucher's co-authors include Daniel B. Costa, Sidhu P. Gangadharan, Paul A. VanderLaan, Erik Folch, Mark S. Huberman, Michael S. Kent, Michael A. Goldstein, Olivier Kocher, Adnan Majid and Norihiro Yamaguchi and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and CHEST Journal.

In The Last Decade

David Boucher

7 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Boucher United States 5 278 199 149 60 33 7 334
Guannan Kang China 6 164 0.6× 183 0.9× 80 0.5× 70 1.2× 32 1.0× 11 275
Giovanni Burrafato Italy 9 139 0.5× 96 0.5× 157 1.1× 64 1.1× 35 1.1× 13 247
Santosh Gupta United States 6 163 0.6× 106 0.5× 122 0.8× 73 1.2× 30 0.9× 15 246
Gianluca Gragnano Italy 11 212 0.8× 201 1.0× 159 1.1× 101 1.7× 47 1.4× 20 336
Takako Okuyama Japan 5 259 0.9× 268 1.3× 167 1.1× 113 1.9× 59 1.8× 12 354
Prabhu Bhagavatheeswaran United States 10 299 1.1× 81 0.4× 384 2.6× 40 0.7× 12 0.4× 13 459
Matthew Labriola United States 6 159 0.6× 82 0.4× 137 0.9× 72 1.2× 15 0.5× 23 238
Linpeng Zheng China 10 150 0.5× 71 0.4× 207 1.4× 77 1.3× 15 0.5× 17 304
Jaclyn P. Lyman United States 6 86 0.3× 184 0.9× 197 1.3× 94 1.6× 35 1.1× 11 313
Kammei Rai Japan 8 138 0.5× 112 0.6× 104 0.7× 144 2.4× 20 0.6× 34 333

Countries citing papers authored by David Boucher

Since Specialization
Citations

This map shows the geographic impact of David Boucher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Boucher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Boucher more than expected).

Fields of papers citing papers by David Boucher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Boucher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Boucher. The network helps show where David Boucher may publish in the future.

Co-authorship network of co-authors of David Boucher

This figure shows the co-authorship network connecting the top 25 collaborators of David Boucher. A scholar is included among the top collaborators of David Boucher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Boucher. David Boucher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Yanagita, Masahiko, Amanda J. Redig, Cloud P. Paweletz, et al.. (2016). A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR -Mutant Non–Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial. Clinical Cancer Research. 22(24). 6010–6020. 92 indexed citations
2.
3.
Redig, Amanda J., Myriam Taibi, Geoffrey R. Oxnard, et al.. (2015). A phase II trial of erlotinib for EGFR mutant NSCLC to prospectively assess biopsy feasibility and acquired resistance at disease progression.. Journal of Clinical Oncology. 33(15_suppl). 8076–8076. 2 indexed citations
4.
Folch, Erik, Adnan Majid, Paul A. VanderLaan, et al.. (2014). Adequacy of Pleural Fluid Cytology and Pleural Biopsies for Multiple Tumor Genotyping Techniques in Non-small Cell Lung Cancer. CHEST Journal. 146(4). 609A–609A. 1 indexed citations
5.
VanderLaan, Paul A., Norihiro Yamaguchi, Erik Folch, et al.. (2014). Success and failure rates of tumor genotyping techniques in routine pathological samples with non-small-cell lung cancer. Lung Cancer. 84(1). 39–44. 118 indexed citations
6.
7.
Folch, Erik, Norihiro Yamaguchi, Paul A. VanderLaan, et al.. (2013). Adequacy of Lymph Node Transbronchial Needle Aspirates Using Convex Probe Endobronchial Ultrasound for Multiple Tumor Genotyping Techniques in Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 8(11). 1438–1444. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guannan Kang Breakdown of academic impact, for papers by Giovanni Burrafato Breakdown of academic impact, for papers by Santosh Gupta Breakdown of academic impact, for papers by Gianluca Gragnano Breakdown of academic impact, for papers by Takako Okuyama Breakdown of academic impact, for papers by Prabhu Bhagavatheeswaran Breakdown of academic impact, for papers by Matthew Labriola Breakdown of academic impact, for papers by Linpeng Zheng Breakdown of academic impact, for papers by Jaclyn P. Lyman Breakdown of academic impact, for papers by Kammei Rai
Rankless by CCL
2026